Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)



Status:Archived
Conditions:Liver Cancer, Cancer, Gastrointestinal, Digestive Disease
Therapuetic Areas:Gastroenterology, Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2010

Use our guide to learn which trials are right for you!


The primary objective of this study is to assess the overall survival (OS) of oral linifanib
given as monotherapy once daily (QD) compared to sorafenib given twice daily (BID) per
standard of care in subjects with advanced or metastatic HCC.



We found this trial at
13
sites
Beverly Hills, California 90211
21
mi
from 91732
Beverly Hills, CA
Click here to add this to my saved trials
2044
mi
from 91732
Canton, OH
Click here to add this to my saved trials
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
815
mi
from 91732
Englewood, CO
Click here to add this to my saved trials
1943
mi
from 91732
Gainesville, GA
Click here to add this to my saved trials
2572
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
2573
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
14
mi
from 91732
LaVerne, CA
Click here to add this to my saved trials
2347
mi
from 91732
Newark, DE
Click here to add this to my saved trials
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
828
mi
from 91732
Portland, OR
Click here to add this to my saved trials
1572
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials